Jinling Pharmaceutical Dividends and Buybacks
Dividend criteria checks 2/6
Jinling Pharmaceutical is a dividend paying company with a current yield of 1.45% that is well covered by earnings.
Key information
1.5%
Dividend yield
-17.3%
Buyback Yield
| Total Shareholder Yield | -15.9% |
| Future Dividend Yield | n/a |
| Dividend Growth | 0.5% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.100 |
| Payout ratio | 77% |
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 000919's dividend payments have been volatile in the past 10 years.
Growing Dividend: 000919's dividend payments have fallen over the past 10 years.
Dividend Yield vs Market
| Jinling Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (000919) | 1.5% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Pharmaceuticals) | 1.7% |
| Analyst forecast (000919) (up to 3 years) | n/a |
Notable Dividend: 000919's dividend (1.45%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 000919's dividend (1.45%) is low compared to the top 25% of dividend payers in the CN market (2.17%).
Earnings Payout to Shareholders
Earnings Coverage: At its current payout ratio (77%), 000919's payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (438.3%), 000919's dividend payments are not well covered by cash flows.